申请人:Eli Lilly and Company
公开号:US06541499B1
公开(公告)日:2003-04-01
The invention relates to novel compounds of formula (I), and their pharmaceutically acceptable salts, as defined herein, processes and intermediates for their preparation, pharmaceutical formulations comprising the novel compounds of formula (I), and the use of the compounds of formula (I) as thrombin inhibitors.
这项发明涉及公式(I)的新化合物及其在此定义的药用可接受盐,用于其制备的过程和中间体,包括公式(I)的新化合物的制药配方,以及将公式(I)的化合物用作凝血酶抑制剂。